- Investing Ideas
- /
- U.S. High Growth Tech and AI Stocks
U.S. High Growth Tech and AI Stocks
Results
234
234 companies
Ascendis Pharma
Market Cap: US$9.3b
A biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$154.68
7D
-7.9%
1Y
1.8%
Lumentum Holdings
Market Cap: US$4.3b
Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LITE
US$62.58
7D
-15.0%
1Y
30.0%
Travere Therapeutics
Market Cap: US$1.7b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$19.68
7D
-7.6%
1Y
169.2%
TG Therapeutics
Market Cap: US$5.8b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$39.86
7D
-6.5%
1Y
169.9%
Alnylam Pharmaceuticals
Market Cap: US$34.8b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$268.46
7D
-7.7%
1Y
75.1%
AVITA Medical
Market Cap: US$230.1m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$8.73
7D
-2.6%
1Y
-45.5%
Alkami Technology
Market Cap: US$2.7b
Provides cloud-based digital banking solutions in the United States.
ALKT
US$26.41
7D
-0.5%
1Y
7.5%
TKO Group Holdings
Market Cap: US$25.6b
Operates as a sports and entertainment company.
TKO
US$149.70
7D
-2.1%
1Y
73.7%
Super Micro Computer
Market Cap: US$20.3b
Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.
SMCI
US$34.26
7D
-17.9%
1Y
-67.0%
Clene
Market Cap: US$27.6m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$3.22
7D
-22.2%
1Y
-62.2%
Legend Biotech
Market Cap: US$6.4b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$35.06
7D
-5.1%
1Y
-37.5%
Alvotech
Market Cap: US$2.9b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$9.55
7D
-17.5%
1Y
-21.8%
Blueprint Medicines
Market Cap: US$5.7b
A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
BPMC
US$88.72
7D
-6.9%
1Y
-8.0%
Palantir Technologies
Market Cap: US$201.3b
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
PLTR
US$85.85
7D
-11.3%
1Y
275.5%
Core Scientific
Market Cap: US$2.2b
Provides digital asset mining services in the United States.
CORZ
US$7.48
7D
-12.1%
1Y
111.3%
Bitdeer Technologies Group
Market Cap: US$1.8b
Operates as a technology company for blockchain and computing.
BTDR
US$9.14
7D
-21.5%
1Y
31.3%
Applied Optoelectronics
Market Cap: US$823.1m
Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.
AAOI
US$16.38
7D
-26.5%
1Y
17.7%
UroGen Pharma
Market Cap: US$516.3m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$11.20
7D
-7.7%
1Y
-25.3%
Roadzen
Market Cap: US$71.6m
Operates as an insurance technology company.
RDZN
US$0.97
7D
-15.3%
1Y
-85.1%
RenovoRx
Market Cap: US$35.6m
A clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.00
7D
4.2%
1Y
-25.4%
Duos Technologies Group
Market Cap: US$44.7m
Designs, develops, deploys, and operates intelligent technology solutions in North America.
DUOT
US$5.31
7D
-13.9%
1Y
22.4%
Silence Therapeutics
Market Cap: US$162.5m
A biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.
SLN
US$3.44
7D
-3.4%
1Y
-84.1%
SideChannel
Market Cap: US$9.8m
SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.
SDCH
US$0.043
7D
11.5%
1Y
-39.6%
Aldeyra Therapeutics
Market Cap: US$398.3m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.
ALDX
US$6.67
7D
1.4%
1Y
104.0%
Vanda Pharmaceuticals
Market Cap: US$273.5m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.69
7D
-1.7%
1Y
14.1%
Abeona Therapeutics
Market Cap: US$241.2m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$4.97
7D
-3.5%
1Y
-31.4%
Capricor Therapeutics
Market Cap: US$525.3m
A clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs.
CAPR
US$11.50
7D
-10.6%
1Y
69.4%
Checkpoint Therapeutics
Market Cap: US$197.3m
A clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.
CKPT
US$4.04
7D
-0.7%
1Y
97.1%
Soleno Therapeutics
Market Cap: US$3.3b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$71.99
7D
46.6%
1Y
68.2%
OS Therapies
Market Cap: US$34.4m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.62
7D
-6.4%
1Y
n/a
SpringWorks Therapeutics
Market Cap: US$3.6b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.
SWTX
US$47.41
7D
-5.0%
1Y
-3.7%
Tenaya Therapeutics
Market Cap: US$104.4m
A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
TNYA
US$0.64
7D
0.9%
1Y
-87.7%
Madrigal Pharmaceuticals
Market Cap: US$7.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$327.87
7D
-5.3%
1Y
28.2%
TruGolf Holdings
Market Cap: US$7.8m
Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.
TRUG
US$0.36
7D
-6.5%
1Y
-69.8%
MeiraGTx Holdings
Market Cap: US$578.0m
A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$7.33
7D
-4.7%
1Y
26.2%
DigitalOcean Holdings
Market Cap: US$3.1b
Through its subsidiaries, operates a cloud computing platform in North America, Europe, Asia, and internationally.
DOCN
US$34.17
7D
-9.8%
1Y
-10.5%